Literature DB >> 28688202

Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT).

Jason H Karnes1,2, Christian M Shaffer3, Robert Cronin4, Lisa Bastarache4, Silvana Gaudieri5,6,7, Ian James7, Rebecca Pavlos7, Heidi E Steiner1, Jonathan D Mosley3, Simon Mallal6,7,8, Joshua C Denny3,4, Elizabeth J Phillips3,8, Dan M Roden3,4,9.   

Abstract

Heparin-induced thrombocytopenia (HIT) is an unpredictable, life-threatening, immune-mediated reaction to heparin. Variation in human leukocyte antigen (HLA) genes is now used to prevent immune-mediated adverse drug reactions. Combinations of HLA alleles and killer cell immunoglobulin-like receptors (KIR) are associated with multiple autoimmune diseases and infections. The objective of this study is to evaluate the association of HLA alleles and KIR types, alone or in the presence of different HLA ligands, with HIT. HIT cases and heparin-exposed controls were identified in BioVU, an electronic health record coupled to a DNA biobank. HLA sequencing and KIR type imputation using Illumina OMNI-Quad data were performed. Odds ratios for HLA alleles and KIR types and HLA*KIR interactions using conditional logistic regressions were determined in the overall population and by race/ethnicity. Analysis was restricted to KIR types and HLA alleles with a frequency greater than 0.01. The p values for HLA and KIR association were corrected by using a false discovery rate q<0.05 and HLA*KIR interactions were considered significant at p<0.05. Sixty-five HIT cases and 350 matched controls were identified. No statistical differences in baseline characteristics were observed between cases and controls. The HLA-DRB3*01:01 allele was significantly associated with HIT in the overall population (odds ratio 2.81 [1.57-5.02], p=2.1×10-4 , q=0.02) and in individuals with European ancestry, independent of other alleles. No KIR types were associated with HIT, although a significant interaction was observed between KIR2DS5 and the HLA-C1 KIR binding group (p=0.03). The HLA-DRB3*01:01 allele was identified as a potential risk factor for HIT. This class II HLA gene and allele represent biologically plausible candidates for influencing HIT pathogenesis. We found limited evidence of the role of KIR types in HIT pathogenesis. Replication and further study of the HLA-DRB3*01:01 association is necessary.
© 2017 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  HLA; electronic health records; heparin-induced thrombocytopenia; immunogenetics; killer cell immunoglobulin-like receptor (KIR); pharmacogenomics

Mesh:

Substances:

Year:  2017        PMID: 28688202      PMCID: PMC5600645          DOI: 10.1002/phar.1983

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  39 in total

1.  Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients.

Authors:  Andreas Greinacher; Beate Farner; Hartmut Kroll; Thomas Kohlmann; Theodore E Warkentin; Petra Eichler
Journal:  Thromb Haemost       Date:  2005-07       Impact factor: 5.249

2.  Evaluation of a method to identify and categorize section headers in clinical documents.

Authors:  Joshua C Denny; Anderson Spickard; Kevin B Johnson; Neeraja B Peterson; Josh F Peterson; Randolph A Miller
Journal:  J Am Med Inform Assoc       Date:  2009-08-28       Impact factor: 4.497

3.  Pitfalls of merging GWAS data: lessons learned in the eMERGE network and quality control procedures to maintain high data quality.

Authors:  Rebecca L Zuvich; Loren L Armstrong; Suzette J Bielinski; Yuki Bradford; Christopher S Carlson; Dana C Crawford; Andrew T Crenshaw; Mariza de Andrade; Kimberly F Doheny; Jonathan L Haines; M Geoffrey Hayes; Gail P Jarvik; Lan Jiang; Iftikhar J Kullo; Rongling Li; Hua Ling; Teri A Manolio; Martha E Matsumoto; Catherine A McCarty; Andrew N McDavid; Daniel B Mirel; Lana M Olson; Justin E Paschall; Elizabeth W Pugh; Luke V Rasmussen; Laura J Rasmussen-Torvik; Stephen D Turner; Russell A Wilke; Marylyn D Ritchie
Journal:  Genet Epidemiol       Date:  2011-12       Impact factor: 2.135

4.  Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent.

Authors:  Jing Yuan; Sheng Guo; David Hall; Anna M Cammett; Supriya Jayadev; Manuel Distel; Stephen Storfer; Zimei Huang; Piroon Mootsikapun; Kiat Ruxrungtham; Daniel Podzamczer; David W Haas
Journal:  AIDS       Date:  2011-06-19       Impact factor: 4.177

5.  Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.

Authors:  Nadine Martel; James Lee; Philip S Wells
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

6.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

7.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

Review 8.  Laboratory diagnosis of immune heparin-induced thrombocytopenia.

Authors:  Theodore E Warkentin; Nancy M Heddle
Journal:  Curr Hematol Rep       Date:  2003-03

9.  Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations.

Authors:  Faviel F González-Galarza; Louise Y C Takeshita; Eduardo J M Santos; Felicity Kempson; Maria Helena Thomaz Maia; Andrea Luciana Soares da Silva; André Luiz Teles e Silva; Gurpreet S Ghattaoraya; Ana Alfirevic; Andrew R Jones; Derek Middleton
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 19.160

10.  Imputation of KIR Types from SNP Variation Data.

Authors:  Damjan Vukcevic; James A Traherne; Sigrid Næss; Eva Ellinghaus; Yoichiro Kamatani; Alexander Dilthey; Mark Lathrop; Tom H Karlsen; Andre Franke; Miriam Moffatt; William Cookson; John Trowsdale; Gil McVean; Stephen Sawcer; Stephen Leslie
Journal:  Am J Hum Genet       Date:  2015-10-01       Impact factor: 11.025

View more
  8 in total

1.  Pharmacogenetics to prevent heparin-induced thrombocytopenia: what do we know?

Authors:  Jason H Karnes
Journal:  Pharmacogenomics       Date:  2018-11-06       Impact factor: 2.533

2.  HLA-DQB1 mismatch increase risk of severe bleeding independently in recipients of allogeneic stem cell transplant.

Authors:  Jiaqian Qi; Rui Zhang; Chengsen Cai; Hong Wang; Meng Zhou; Wenhong Shen; Yaqiong Tang; Tingting Pan; Depei Wu; Yue Han
Journal:  Ann Hematol       Date:  2021-04-12       Impact factor: 3.673

Review 3.  Heparin-Induced Thrombocytopenia: A Focus on Thrombosis.

Authors:  Gowthami M Arepally; Anand Padmanabhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

4.  PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reaction.

Authors:  Elise Miller; Charles Norwood; Jason B Giles; Rachel Huddart; Jason H Karnes; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2022-04-01       Impact factor: 2.089

Review 5.  Quantitative and Qualitative Platelet Derangements in Cardiac Surgery and Extracorporeal Life Support.

Authors:  Enrico Squiccimarro; Federica Jiritano; Giuseppe Filiberto Serraino; Hugo Ten Cate; Domenico Paparella; Roberto Lorusso
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

Review 6.  Elucidation of Cellular Contributions to Heparin-Induced Thrombocytopenia Using Omic Approaches.

Authors:  Jason B Giles; Elise C Miller; Heidi E Steiner; Jason H Karnes
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

7.  A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2.

Authors:  Anne Louise Tølbøll Sørensen; Magalie Rolland; Jacob Hartmann; Zitta Barrella Harboe; Casper Roed; Tomas Ø Jensen; Lilian Kolte; Daniel El Fassi; Jens Hillingsø; Aneta Radziwon-Balicka; Robert Sebastian Soyka; Klaus Hansen; Nikolai Kirkby; Jens P Goetze; Mikkel Gybel-Brask; Eva Birgitte Leinøe; Anne-Mette Hvas; Peter Kampmann; Jakob Stensballe
Journal:  Blood Adv       Date:  2021-06-22

8.  Onset of type 1 diabetes mellitus and heparin-induced thrombocytopenia in a patient with Basedow's disease and idiopathic thrombocytopenic purpura: Novel combination as autoimmune polyglandular syndrome.

Authors:  Tomoe Kinoshita; Shinji Kamei; Yoshiko Nakamura; Masashi Shimoda; Takatoshi Anno; Atsushi Obata; Tomohiko Kimura; Hidenori Hirukawa; Fuminori Tatsumi; Kenji Kohara; Shuhei Nakanishi; Tomoatsu Mune; Kohei Kaku; Hideaki Kaneto
Journal:  J Diabetes Investig       Date:  2018-06-15       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.